These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26489268)

  • 1. Protecting Persons Aged 65 Years and Older Against Pneumococcal Disease.
    Michigan Department of Community Health
    Mich Med; 2015; 114(1):20. PubMed ID: 26489268
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine Update: Recommendation for conjugate pneumococcal and pneumococcal polysaccharide vaccines in adults older than 65 years.
    Niemi SA; Foster SL; Hayney MS
    J Am Pharm Assoc (2003); 2015; 55(2):212, 214-5. PubMed ID: 25749266
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumococcal vaccine for adults.
    Med Lett Drugs Ther; 2012 Oct; 54(1402):87-8. PubMed ID: 23114739
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expanded approval for 13-valent pneumococcal conjugate vaccine].
    Pneumologie; 2015 Apr; 69(4):245. PubMed ID: 26038781
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pneumococcal vaccines in adults: an update].
    Blamey R
    Rev Chilena Infectol; 2014 Oct; 31(5):607-9. PubMed ID: 25491461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conjugate pneumococcal vaccines in pediatric population: up to date].
    Hausdorff W; Lepetic A; De Antonio R
    Rev Chilena Infectol; 2014 Dec; 31(6):763-4. PubMed ID: 25679940
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.
    Kyaw MH; Jones IG; Campbell H
    Acta Paediatr; 2001 May; 90(5):473-6. PubMed ID: 11430703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pneumococcal conjugate vaccine in children and the emergence of serotype 19A].
    Lepetic A; De Antonio R; Nieto G J
    Rev Chilena Infectol; 2016 Dec; 33(6):707-709. PubMed ID: 28146201
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(21):394-5. PubMed ID: 22647745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 10-valent conjugate vaccine for some countries.
    Prescrire Int; 2011 Jan; 20(112):8. PubMed ID: 21462783
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on the new pneumococcal conjugate vaccine.
    Holland MJ
    Pediatr Ann; 2001 Sep; 30(9):515-6. PubMed ID: 11554259
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].
    de Arístegui Fernández J; Corretger Rauet JM; García Martín F; Hernández-Sampelayo T; Moraga Llop FA; Rodrigo Gonzalo De Liria C; Ruiz Contreras J;
    An Esp Pediatr; 2002 Jan; 56(1):79-90. PubMed ID: 11792258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccine--relevance for developing countries.
    Mulholland K
    Indian Pediatr; 2001 May; 38(5):453-60. PubMed ID: 11359971
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance.
    Vergison A; Hanquet G
    Pediatr Infect Dis J; 2012 Apr; 31(4):400-3. PubMed ID: 22418653
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
    Haveman LM; Geelen SP; Sanders EA; Wolfs TF
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal vaccination for Indian children.
    Levine OS; Cherian T
    Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301
    [No Abstract]   [Full Text] [Related]  

  • 19. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
    de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latin American Pneumococcal Disease Conference: prevention now and in the future. Foreword.
    Dagan R
    Vaccine; 2009 Aug; 27 Suppl 3():C1-2. PubMed ID: 19520202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.